Opinion | Sexuality

A New Frontier in Pro-Life Stem-Cell Research

FDA-backed Georgia researchers hope stem cells from umbilical cord blood will effectively treat cerebral palsy.

A team of researchers at Georgia's health science university, the Medical College of Georgia (MCG), announced last week that they are conducting a clinical trial using stem cells from umbilical-cord blood as a treatment for cerebral palsy. The trial will build on a successful series of past tests using adult stem cells in regenerative medicine.

"Evidence up to this point has been purely anecdotal," said James Carroll, chief of pediatric neurology at the MCG and principal investigator on the study. "While a variety of cord blood stem-cell therapies have been used successfully for more than 20 years, this study is breaking new ground in advancing therapies for brain injury."

MCG's is the first clinical trial using adult stem cells approved by the Food and Drug Administration (FDA), and comes on the heels of last month's announcement of the first FDA-approved trial of embryonic stem-cell treatment. FDA approval generally means enough funding and prior research has accumulated to make a heavily ...

Subscriber access only You have reached the end of this Article Preview
To continue reading, subscribe now. Subscribers have full digital access.
Already a CT subscriber? for full digital access.

Support our work

Subscribe to CT and get one year free.

Read These Next

hide this
Access The Archives

Member-Only Access

Subscribe to Christianity Today to continue reading this article from CT's digital archives.


Already a subscriber? to continue reading.